社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Safe Pro Group Inc(SPAI)
盘后
2.79
-0.16
-5.42%
19:13 EDT
2.95
+0.03
+1.03%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
小虎周报
·
2024-09-02
一周IPO观察：卡罗特、美的集团过讯，丰巢、赤峰黄金递表，朴荷生物美股递表
港股IPO观察截止2024年的第35周，港交所无新股上市，1只新股招股，2家新通过聆讯，5家递交招股书。当周上市无当周招股建设工程检测检验服务公司集信
$集信国控(08629)$
通过聆讯厨具品牌卡罗特CAROTE智能家居和商业及工业解决方案供应商
$美的集团(000333)$
递表公司抗体偶联药物(ADC)领域的生物医药公司映恩生物行业领先的末端物流解决方案供货商丰巢
$顺丰控股(002352)$
动力电池系统供货商幂源科技储能电池及系统公司双登集团中国最大的民营黄金生产商
$赤峰黄金(600988)$
（A+H）其他
$电讯盈科(00008)$
李泽楷旗下保险公司富卫集团最早于9月重新提交香港IPO申请创新型生物制药公司华芢生物接证监会反馈意见，涉人类遗传资源合规厨具品牌卡罗特CAROTE通过聆讯8月30日，来自浙江杭州的卡罗特在港交所披露聆讯后的招股书，或很快在香港主板挂牌上市。其于2024年3月8日在港交所递表。法巴、招银国际联合保荐。公司成立于2007年，作全球厨具品牌，为客户提供实用、设计精良且价格合理的产品，目前已在中国、美国、西欧、东南亚及日本等主要市场的在线厨具细分领域建立卓越地位，已成为全球增长最快的知名厨具品牌之一。卡罗特的品牌已在全球主要市场的在线炊具行业占据显著地位，根据灼识咨询报告，按2023年的零售额计，卡罗特在中国排名第四，在美国排名
一周IPO观察：卡罗特、美的集团过讯，丰巢、赤峰黄金递表，朴荷生物美股递表
# .SPX频创新高！年末能否站上6000点？
回复
1
点赞
2
编组 21备份 2
分享
举报
美股之家
·
2024-08-15
本周五美股IPO预告：云学堂(YXT)+文远知行(WRD)
本周五即将进行IPO上市的共有3家公司，分别是中概股文远知行(WRD)、中概股云学堂(YXT)和Safe Pro Group Inc.(SPAI)，下面为大家详细介绍。新股资讯请关注公众号：美港股百科全书（mggbkqs） 一、文远知行(WRD)
$文远知行(WRD)$
文远知行WeRide(Nasdaq:WRD)成立于2017年，总部位于中国广州，全职雇员2,227人，致力于通过构建公司的WeRide One平台来释放自动驾驶的真正力量，这是文远知行的基础模型和业务支柱，由先进的智能模型和公司在开放道路运营中无与伦比的经验提供支持。 文远知行（WeRide）宣布计划发行 650 万股美国存托凭证，发行价区间为 15.50 至 18.50 美元，募资 1.1 亿美元。Bosch已表示有意在此次发行中购买 1 亿美元美国存托凭证。该公司还预计将通过私募额外募资 3.21 亿美元。按照提议区间的中间值计算，文远知行的完全摊薄市值将达到 50 亿美元。 摩根士丹利、摩根大通和中金公司是此次交易的联席账簿管理人。 二、云学堂(YXT)
$云学堂(YXT)$
云学堂 YXT.COM GROUP HOLDING LIMITED(YXT)创立于2011年，总部位于中国苏州，全职雇员744人，是一家科技企业，为客户提供数字化企业学习解决方案服务，其中包括：软件SaaS服务、内容解决方案服务、数字化企业学习运营服务，是企业培训领域的创新型平台公司。 云学堂宣布计划发行 280 万股美国存托凭证，发行价区间为 11 至 13 美元，募资 3300 万美元。按照提议区间的中间值计算，YXT.COM GROUP HOLDING 的市值将达到 6
本周五美股IPO预告：云学堂(YXT)+文远知行(WRD)
# IPO情报局
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小虎周报
·
2024-08-19
一周IPO观察：同源康香港招股，汇舸环保递表，云学堂美股上市，文远知行延期
港股IPO观察截止2024年的第33周，港交所无新股上市，1只新股招股，无新通过聆讯，3家递交招股书。当周上市无当周招股肺癌领域差异化靶向疗法生物医药公司
$同源康医药 -B(02410)$
通过聆讯无递表公司领先的船舶ESG解决方案提供商汇舸环保合成生物学技术驱动的肿瘤创新药医药公司华昊中天综合智慧城市解决方案公司文达通其他
$新秀丽(01910)$
决定赴美国双重上市，提高股份流动性李嘉诚旗下
$长江基建集团(01038)$
申请在伦交所第二上市$恒力集团分拆造船业务在香港上市，募资1亿美元
$奈雪的茶(02150)$
预警将由盈转亏后，蜜雪冰城、古茗、沪上阿姨，香港IPO招股书均无推进，已失效华昊中天递交IPO招股书8月12日，北京华昊中天生物医药在港交所递交招股书，拟在香港IPO上市。这是继其于2024年1月29日递表失效后的再一次申请。建银国际、中信建投国际为其联席保荐人公司成立于2002年，作为一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药，公司成功开发了专注于微生物代谢产物新药研发的三大核心技术平台，包括组合生物合成平台、微生物大规模发酵生产技术平台、微生物药物制剂开发平台，并建立了多元的产品组合，包括1款已商业化产品及由19个项目组成的管线。华昊中天的核心产品优替德隆注射液于2021年获得国家药监局批准上市，用于治疗复发或转移性晚期乳腺癌，于2023年3月被纳入2022年国家医保药品目录。优替德隆作为一款创新的微管抑制剂类药
一周IPO观察：同源康香港招股，汇舸环保递表，云学堂美股上市，文远知行延期
# 网易逆势破新高！中概陆续放榜，你看好谁？
回复
1
点赞
2
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Safe Pro Group Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.safeprogroup.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Safe Pro Group Inc.于2021年12月15日在特拉华州注册成立。他们是一家专注于创新安全和保护解决方案的公司，特别是先进的人工智能和机器学习软件技术，用于创建强大的数据集，这些数据集来源于对航空图像、防弹和防爆个人防护设备的分析，并提供关键任务的空中管理服务。
05-16 04:02
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-09
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
03-29
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024-11-15
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024-11-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-10-04
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-09-26
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024-09-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-09-20
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
2024-09-11
超过5%披露
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024-09-11
超过5%披露
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024-09-11
超过5%披露
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024-09-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-08-10
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-08-10
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
3.04
今开
2.91
量比
1.13
最低
2.75
昨收
2.92
换手率
1.03%
热议股票
{"pagemeta":{"title":"Safe Pro Group Inc(SPAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Safe Pro Group Inc(SPAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Safe Pro Group Inc,SPAI,Safe Pro Group Inc股票,Safe Pro Group Inc股票老虎,Safe Pro Group Inc股票老虎国际,Safe Pro Group Inc行情,Safe Pro Group Inc股票行情,Safe Pro Group Inc股价,Safe Pro Group Inc股市,Safe Pro Group Inc股票价格,Safe Pro Group Inc股票交易,Safe Pro Group Inc股票购买,Safe Pro Group Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Safe Pro Group Inc(SPAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Safe Pro Group Inc(SPAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"SPAI","data":{"stockData":{"symbol":"SPAI","market":"US","secType":"STK","nameCN":"Safe Pro Group Inc","latestPrice":2.95,"timestamp":1747425600000,"preClose":2.92,"halted":0,"volume":46635,"hourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.95,"latestTime":"19:13 EDT","volume":1000,"amount":2820.1,"timestamp":1747437212254},"delay":0,"floatShares":4527900,"shares":15172185,"eps":-0.699921,"marketStatus":"休市中","change":0.03,"latestTime":"05-16 16:00:00 EDT","open":2.91,"high":3.0398,"low":2.75,"amount":132212.239632,"amplitude":0.099247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.699921,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"listingDate":1724817600000,"exchange":"NASDAQ","adjPreClose":2.92,"preHourTrading":{"tag":"盘前","latestPrice":2.94,"preClose":2.94,"latestTime":"08:48 EDT","volume":503,"amount":1483.479943,"timestamp":1747399692460},"postHourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.95,"latestTime":"19:13 EDT","volume":1000,"amount":2820.1,"timestamp":1747437212254},"volumeRatio":1.13496977390772},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.344992234860912","cardData":[{"tweetId":"344992234860912","author":{"authorId":"36979109942400","idStr":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","userType":4,"introduction":"老虎股票官方帐号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":565291,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"一周IPO观察：卡罗特、美的集团过讯，丰巢、赤峰黄金递表，朴荷生物美股递表","digest":"港股IPO观察截止2024年的第35周，港交所无新股上市，1只新股招股，2家新通过聆讯，5家递交招股书。当周上市无当周招股建设工程检测检验服务公司集信 <a href=\"https://laohu8.com/S/08629\">$集信国控(08629)$</a> 通过聆讯厨具品牌卡罗特CAROTE智能家居和商业及工业解决方案供应商 <a href=\"https://laohu8.com/S/000333\">$美的集团(000333)$</a> 递表公司抗体偶联药物(ADC)领域的生物医药公司映恩生物行业领先的末端物流解决方案供货商丰巢 <a href=\"https://laohu8.com/S/002352\">$顺丰控股(002352)$</a> 动力电池系统供货商幂源科技储能电池及系统公司双登集团中国最大的民营黄金生产商 <a href=\"https://laohu8.com/S/600988\">$赤峰黄金(600988)$</a> （A+H）其他 <a href=\"https://laohu8.com/S/00008\">$电讯盈科(00008)$</a> 李泽楷旗下保险公司富卫集团最早于9月重新提交香港IPO申请创新型生物制药公司华芢生物接证监会反馈意见，涉人类遗传资源合规厨具品牌卡罗特CAROTE通过聆讯8月30日，来自浙江杭州的卡罗特在港交所披露聆讯后的招股书，或很快在香港主板挂牌上市。其于2024年3月8日在港交所递表。法巴、招银国际联合保荐。公司成立于2007年，作全球厨具品牌，为客户提供实用、设计精良且价格合理的产品，目前已在中国、美国、西欧、东南亚及日本等主要市场的在线厨具细分领域建立卓越地位，已成为全球增长最快的知名厨具品牌之一。卡罗特的品牌已在全球主要市场的在线炊具行业占据显著地位，根据灼识咨询报告，按2023年的零售额计，卡罗特在中国排名第四，在美国排名","plainDigest":"港股IPO观察截止2024年的第35周，港交所无新股上市，1只新股招股，2家新通过聆讯，5家递交招股书。当周上市无当周招股建设工程检测检验服务公司集信 $集信国控(08629)$ 通过聆讯厨具品牌卡罗特CAROTE智能家居和商业及工业解决方案供应商 $美的集团(000333)$ 递表公司抗体偶联药物(ADC)领域的生物医药公司映恩生物行业领先的末端物流解决方案供货商丰巢 $顺丰控股(002352)$ 动力电池系统供货商幂源科技储能电池及系统公司双登集团中国最大的民营黄金生产商 $赤峰黄金(600988)$ （A+H）其他 $电讯盈科(00008)$ 李泽楷旗下保险公司富卫集团最早于9月重新提交香港IPO申请创新型生物制药公司华芢生物接证监会反馈意见，涉人类遗传资源合规厨具品牌卡罗特CAROTE通过聆讯8月30日，来自浙江杭州的卡罗特在港交所披露聆讯后的招股书，或很快在香港主板挂牌上市。其于2024年3月8日在港交所递表。法巴、招银国际联合保荐。公司成立于2007年，作全球厨具品牌，为客户提供实用、设计精良且价格合理的产品，目前已在中国、美国、西欧、东南亚及日本等主要市场的在线厨具细分领域建立卓越地位，已成为全球增长最快的知名厨具品牌之一。卡罗特的品牌已在全球主要市场的在线炊具行业占据显著地位，根据灼识咨询报告，按2023年的零售额计，卡罗特在中国排名第四，在美国排名","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1725248117148,"gmtModify":1725248149161,"symbols":["WETO","000333","CCTS","IBGR","600988","SPAI","ANSC","PTHL","TDTH","AFA.AU","08629","CUPR","00008","YMAT","AZI","GLXG","PLMI","PMAX","CND","002352","JBDI","MCAG","PCCWY"],"themeIds":["2f78a4c36291496c859562eb6fe70f20","0e78c0db8cb445f7b26f2b55e79c0399","e4363384c4254650b897c0f13fe1588f","cc65bfe8ff7145cf8db4716572f98414"],"themes":[{"themeId":"2f78a4c36291496c859562eb6fe70f20","themeType":0,"name":".SPX频创新高！年末能否站上6000点？"}],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":14533,"likeCount":2,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/344992234860912","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6760,"displayRows":2,"foldSize":0,"authorId":"36979109942400"}]},{"cardType":"TWEET","cardId":"TWEET.338600487903568","cardData":[{"tweetId":"338600487903568","author":{"authorId":"10790722010898","idStr":"10790722010898","name":"美股之家","avatar":"https://static.tigerbbs.com/4a72f7d16c06b759c1ceb59ddc3be2d8","userType":6,"introduction":"美股之家（www.mg21.com），专注美股投资","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":8743,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"本周五美股IPO预告：云学堂(YXT)+文远知行(WRD)","digest":"本周五即将进行IPO上市的共有3家公司，分别是中概股文远知行(WRD)、中概股云学堂(YXT)和Safe Pro Group Inc.(SPAI)，下面为大家详细介绍。新股资讯请关注公众号：美港股百科全书（mggbkqs） 一、文远知行(WRD) <a href=\"https://laohu8.com/S/WRD\">$文远知行(WRD)$</a> 文远知行WeRide(Nasdaq:WRD)成立于2017年，总部位于中国广州，全职雇员2,227人，致力于通过构建公司的WeRide One平台来释放自动驾驶的真正力量，这是文远知行的基础模型和业务支柱，由先进的智能模型和公司在开放道路运营中无与伦比的经验提供支持。 文远知行（WeRide）宣布计划发行 650 万股美国存托凭证，发行价区间为 15.50 至 18.50 美元，募资 1.1 亿美元。Bosch已表示有意在此次发行中购买 1 亿美元美国存托凭证。该公司还预计将通过私募额外募资 3.21 亿美元。按照提议区间的中间值计算，文远知行的完全摊薄市值将达到 50 亿美元。 摩根士丹利、摩根大通和中金公司是此次交易的联席账簿管理人。 二、云学堂(YXT) <a href=\"https://laohu8.com/S/YXT\">$云学堂(YXT)$</a> 云学堂 YXT.COM GROUP HOLDING LIMITED(YXT)创立于2011年，总部位于中国苏州，全职雇员744人，是一家科技企业，为客户提供数字化企业学习解决方案服务，其中包括：软件SaaS服务、内容解决方案服务、数字化企业学习运营服务，是企业培训领域的创新型平台公司。 云学堂宣布计划发行 280 万股美国存托凭证，发行价区间为 11 至 13 美元，募资 3300 万美元。按照提议区间的中间值计算，YXT.COM GROUP HOLDING 的市值将达到 6","plainDigest":"本周五即将进行IPO上市的共有3家公司，分别是中概股文远知行(WRD)、中概股云学堂(YXT)和Safe Pro Group Inc.(SPAI)，下面为大家详细介绍。新股资讯请关注公众号：美港股百科全书（mggbkqs） 一、文远知行(WRD) $文远知行(WRD)$ 文远知行WeRide(Nasdaq:WRD)成立于2017年，总部位于中国广州，全职雇员2,227人，致力于通过构建公司的WeRide One平台来释放自动驾驶的真正力量，这是文远知行的基础模型和业务支柱，由先进的智能模型和公司在开放道路运营中无与伦比的经验提供支持。 文远知行（WeRide）宣布计划发行 650 万股美国存托凭证，发行价区间为 15.50 至 18.50 美元，募资 1.1 亿美元。Bosch已表示有意在此次发行中购买 1 亿美元美国存托凭证。该公司还预计将通过私募额外募资 3.21 亿美元。按照提议区间的中间值计算，文远知行的完全摊薄市值将达到 50 亿美元。 摩根士丹利、摩根大通和中金公司是此次交易的联席账簿管理人。 二、云学堂(YXT) $云学堂(YXT)$ 云学堂 YXT.COM GROUP HOLDING LIMITED(YXT)创立于2011年，总部位于中国苏州，全职雇员744人，是一家科技企业，为客户提供数字化企业学习解决方案服务，其中包括：软件SaaS服务、内容解决方案服务、数字化企业学习运营服务，是企业培训领域的创新型平台公司。 云学堂宣布计划发行 280 万股美国存托凭证，发行价区间为 11 至 13 美元，募资 3300 万美元。按照提议区间的中间值计算，YXT.COM GROUP HOLDING 的市值将达到 6","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1723674704918,"gmtModify":1723681727452,"symbols":["YXT","WRD","SPAI"],"themeIds":["0e78c0db8cb445f7b26f2b55e79c0399"],"themes":[{"themeId":"0e78c0db8cb445f7b26f2b55e79c0399","themeType":0,"name":"IPO情报局"}],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/0a25f983da0398a05ed70ac25a3ee48a","width":"800","height":"600"},{"url":"https://static.tigerbbs.com/739f51def22e427caaa71a093037a860","width":"600","height":"450"},{"url":"https://static.tigerbbs.com/37aa78780ff8377c8b4c9e87b9c106a0","width":"800","height":"600"}],"repostCount":2,"viewCount":4877,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/338600487903568","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1794,"displayRows":2,"foldSize":0,"authorId":"10790722010898"}]},{"cardType":"TWEET","cardId":"TWEET.340081825706160","cardData":[{"tweetId":"340081825706160","author":{"authorId":"36979109942400","idStr":"36979109942400","name":"小虎周报","avatar":"https://static.laohu8.com/f7b172cf773c77a3f0df67695c126b51","userType":4,"introduction":"老虎股票官方帐号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":565291,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"一周IPO观察：同源康香港招股，汇舸环保递表，云学堂美股上市，文远知行延期","digest":"港股IPO观察截止2024年的第33周，港交所无新股上市，1只新股招股，无新通过聆讯，3家递交招股书。当周上市无当周招股肺癌领域差异化靶向疗法生物医药公司 <a href=\"https://laohu8.com/S/02410\">$同源康医药 -B(02410)$</a> 通过聆讯无递表公司领先的船舶ESG解决方案提供商汇舸环保合成生物学技术驱动的肿瘤创新药医药公司华昊中天综合智慧城市解决方案公司文达通其他 <a href=\"https://laohu8.com/S/01910\">$新秀丽(01910)$</a> 决定赴美国双重上市，提高股份流动性李嘉诚旗下 <a href=\"https://laohu8.com/S/01038\">$长江基建集团(01038)$</a> 申请在伦交所第二上市$恒力集团分拆造船业务在香港上市，募资1亿美元 <a href=\"https://laohu8.com/S/02150\">$奈雪的茶(02150)$</a> 预警将由盈转亏后，蜜雪冰城、古茗、沪上阿姨，香港IPO招股书均无推进，已失效华昊中天递交IPO招股书8月12日，北京华昊中天生物医药在港交所递交招股书，拟在香港IPO上市。这是继其于2024年1月29日递表失效后的再一次申请。建银国际、中信建投国际为其联席保荐人公司成立于2002年，作为一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药，公司成功开发了专注于微生物代谢产物新药研发的三大核心技术平台，包括组合生物合成平台、微生物大规模发酵生产技术平台、微生物药物制剂开发平台，并建立了多元的产品组合，包括1款已商业化产品及由19个项目组成的管线。华昊中天的核心产品优替德隆注射液于2021年获得国家药监局批准上市，用于治疗复发或转移性晚期乳腺癌，于2023年3月被纳入2022年国家医保药品目录。优替德隆作为一款创新的微管抑制剂类药","plainDigest":"港股IPO观察截止2024年的第33周，港交所无新股上市，1只新股招股，无新通过聆讯，3家递交招股书。当周上市无当周招股肺癌领域差异化靶向疗法生物医药公司 $同源康医药 -B(02410)$ 通过聆讯无递表公司领先的船舶ESG解决方案提供商汇舸环保合成生物学技术驱动的肿瘤创新药医药公司华昊中天综合智慧城市解决方案公司文达通其他 $新秀丽(01910)$ 决定赴美国双重上市，提高股份流动性李嘉诚旗下 $长江基建集团(01038)$ 申请在伦交所第二上市$恒力集团分拆造船业务在香港上市，募资1亿美元 $奈雪的茶(02150)$ 预警将由盈转亏后，蜜雪冰城、古茗、沪上阿姨，香港IPO招股书均无推进，已失效华昊中天递交IPO招股书8月12日，北京华昊中天生物医药在港交所递交招股书，拟在香港IPO上市。这是继其于2024年1月29日递表失效后的再一次申请。建银国际、中信建投国际为其联席保荐人公司成立于2002年，作为一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药，公司成功开发了专注于微生物代谢产物新药研发的三大核心技术平台，包括组合生物合成平台、微生物大规模发酵生产技术平台、微生物药物制剂开发平台，并建立了多元的产品组合，包括1款已商业化产品及由19个项目组成的管线。华昊中天的核心产品优替德隆注射液于2021年获得国家药监局批准上市，用于治疗复发或转移性晚期乳腺癌，于2023年3月被纳入2022年国家医保药品目录。优替德隆作为一款创新的微管抑制剂类药","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1724035704157,"gmtModify":1724036106033,"symbols":["SPAI","TDTH","01038","WRD","02410","01910","02150","RITR","SKK","YXT","ACTU","CKISY","SMSEY"],"themeIds":["709fe710809f461f864f26ad95af2c18","0e78c0db8cb445f7b26f2b55e79c0399","44a7a444b0e44f64b95e3e2d4e219bc8"],"themes":[{"themeId":"709fe710809f461f864f26ad95af2c18","themeType":0,"name":"网易逆势破新高！中概陆续放榜，你看好谁？"}],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":16725,"likeCount":2,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/340081825706160","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4283,"displayRows":2,"foldSize":0,"authorId":"36979109942400"}]}],"size":3,"extra":{"requestId":"8c171c0de92246358640c29f167b681d","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19653697","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225010842-SPAI","pdf_url":"","pub_time":1747339324000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPAI","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001641172-25-010842-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225010842/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILET1wpiFBetB48vkzs","market":"us","size":1048148},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225010842/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILED7tqqfe4EPZ7DcRz","market":"us","size":10491},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225010842/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILE28XK7e5oqqs3mqAt","market":"us","size":10720},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225010842/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEBFNqWBPnKmPwXKe5","market":"us","size":12159}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-16 04:02","pubTimestamp":1747339324,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19624924","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225009519-SPAI","pdf_url":"","pub_time":1746763200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SPAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225009519/0001641172-25-009519-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225009519/ex3-1.htm","primary":true,"translateUrl":"","linkName":"ex3-1.htm","type":"EX-3.1","id":"NTFILECzurcCcGLfJ3hxHy","market":"us","size":100555},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225009519/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEE8WUFMR86VKoMJT4","market":"us","size":54186},{"description":"EX-4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225009519/ex4-1.htm","primary":false,"translateUrl":"","linkName":"ex4-1.htm","type":"EX-4.1","id":"NTFILEGpnWnXerkgu1aVnY","market":"us","size":79540},{"description":"EX-10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225009519/ex10-1.htm","primary":false,"translateUrl":"","linkName":"ex10-1.htm","type":"EX-10.1","id":"NTFILEGubhrMYWsNFfAgmi","market":"us","size":194587}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-09 12:00","pubTimestamp":1746763200,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19328722","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225001383-SPAI","pdf_url":"","pub_time":1743204538000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"SPAI","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001641172-25-001383-index.html","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/form10-k.htm","primary":true,"translateUrl":"","linkName":"form10-k.htm","type":"10-K","id":"NTFILE8JRFSFtShT6ztMri","market":"us","size":2006850},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex4-5.htm","primary":false,"translateUrl":"","linkName":"ex4-5.htm","type":"EX-4.5","id":"NTFILE3XRE3nG46Ru7YxyM","market":"us","size":20959},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex19-1.htm","primary":false,"translateUrl":"","linkName":"ex19-1.htm","type":"EX-19.1","id":"NTFILE4NCTqJhD1ePPfhLW","market":"us","size":82781},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEFjm5Y1RoCLpBDhBJ","market":"us","size":8461},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex23-2.htm","primary":false,"translateUrl":"","linkName":"ex23-2.htm","type":"EX-23.2","id":"NTFILE5CiPwVrj31sFXZWV","market":"us","size":3655},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILEE42oxwLagh7sfDbN","market":"us","size":16267},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILE99e73ExUSiUHM8XR","market":"us","size":16149},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEBS5HQMv4ZTWqGK9E","market":"us","size":7784},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex32-2.htm","primary":false,"translateUrl":"","linkName":"ex32-2.htm","type":"EX-32.2","id":"NTFILEH38SVMwp4d4oLDqJ","market":"us","size":7652},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex97-1.htm","primary":false,"translateUrl":"","linkName":"ex97-1.htm","type":"EX-97.1","id":"NTFILEB2DNVcFRBnke5y7r","market":"us","size":29667},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/ex23-4_001.jpg","primary":false,"translateUrl":"","linkName":"ex23-4_001.jpg","type":"GRAPHIC","id":"NTFILEH4F1h2RwyZnTj1WZ","market":"us","size":5656},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/audit_001.jpg","primary":false,"translateUrl":"","linkName":"audit_001.jpg","type":"GRAPHIC","id":"NTFILE8DLCYRBu7nyfQt7f","market":"us","size":5656},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000164117225001383/fin_001.jpg","primary":false,"translateUrl":"","linkName":"fin_001.jpg","type":"GRAPHIC","id":"NTFILEDtKVHWMzJ8h4F2Qq","market":"us","size":62526}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-29 07:28","pubTimestamp":1743204538,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18838354","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224045955-SPAI","pdf_url":"","pub_time":1731620081000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPAI","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001493152-24-045955-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045955/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILEfuG3zDUomvtxnS9H","market":"us","size":1845942},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045955/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILEEGvCua1AXsqYpjdm","market":"us","size":10902},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045955/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILEER5faNwKHNhibMyT","market":"us","size":11370},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045955/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILE9SWXJZ67Ra4s6LRN","market":"us","size":12424}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2024-11-15 05:34","pubTimestamp":1731620081,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18838361","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224045855-SPAI","pdf_url":"","pub_time":1731618484000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SPAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001493152-24-045855-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045855/ex99-1.htm","primary":true,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE79gieq73TnT5zjGM","market":"us","size":22400},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045855/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEF4yWamCPRhftoApp","market":"us","size":36929},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224045855/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE3gNK6JDBCCSo3zp2","market":"us","size":10550}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-11-15 05:08","pubTimestamp":1731618484,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18680673","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224039528-SPAI","pdf_url":"","pub_time":1728014400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SPAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224039528/0001493152-24-039528-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224039528/ex16-1.htm","primary":true,"translateUrl":"","linkName":"ex16-1.htm","type":"EX-16.1","id":"NTFILEJ8Z8TRQca4zNW5QV","market":"us","size":8749},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224039528/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE4eoopF1GPpd3iRLR","market":"us","size":41252},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224039528/ex16-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex16-1_001.jpg","type":"GRAPHIC","id":"NTFILECQhNVu7bnshYjBej","market":"us","size":12535},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224039528/ex16-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex16-1_002.jpg","type":"GRAPHIC","id":"NTFILE6KuPXcx74V9dze9B","market":"us","size":5071}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-10-04 12:00","pubTimestamp":1728014400,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01项：注册人注册会计师的变更；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18651524","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224038306-SPAI","pdf_url":"","pub_time":1727323200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPAI","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038306/0001493152-24-038306-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038306/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILECtEqPUNB4HU684AA","market":"us","size":1442344},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038306/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILEi7myeAdr2Amyys6Q","market":"us","size":10878},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038306/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILE9DKHikV5za53WBhU","market":"us","size":11102},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038306/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEtgHB1Ne9k9ADQQSe","market":"us","size":12264}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2024-09-26 12:00","pubTimestamp":1727323200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18650708","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224038216-SPAI","pdf_url":"","pub_time":1727323200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SPAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038216/0001493152-24-038216-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038216/ex99-1.htm","primary":true,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE9wWEcPvepYbUiJrH","market":"us","size":21789},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038216/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE211Au1eQ9ApBdwje","market":"us","size":40284},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224038216/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE8cAemVRnkFS5XRHi","market":"us","size":4850}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-09-26 12:00","pubTimestamp":1727323200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18634835","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224037705-SPAI","pdf_url":"","pub_time":1726804800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"SPAI","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/0001493152-24-037705-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/forms-8.htm","primary":true,"translateUrl":"","linkName":"forms-8.htm","type":"S-8","id":"NTFILEhTxFFWSGaXoURUqQ","market":"us","size":82409},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILEEcgJeR6cNQWxui6i","market":"us","size":16428},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEGYxwFJce8XAkFotD","market":"us","size":4249},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/ex99-1.htm","primary":false,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE6JinnCqaxSUkVXPY","market":"us","size":209875},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILEDZqCxL3S49c8DaYE","market":"us","size":16213},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224037705/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE5H64AYofW9cWQYJS","market":"us","size":16140}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-09-20 12:00","pubTimestamp":1726804800,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18604558","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224035873-SPAI","pdf_url":"","pub_time":1726027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","symbol":"SPAI","title":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035873/0001493152-24-035873-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035873/formsc13d.htm","primary":true,"translateUrl":"","linkName":"formsc13d.htm","type":"SC 13D","id":"NTFILE4aFGcNrS9C9yK58D","market":"us","size":81383},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035873/ex3.htm","primary":false,"translateUrl":"","linkName":"ex3.htm","type":"EX-3","id":"NTFILEBUGBe9qur49CS3fE","market":"us","size":22732}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-09-11 12:00","pubTimestamp":1726027200,"title_zh":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18604519","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224035871-SPAI","pdf_url":"","pub_time":1726027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","symbol":"SPAI","title":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035871/0001493152-24-035871-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1257950/000149315224035871/formsc13d.htm","primary":true,"translateUrl":"","linkName":"formsc13d.htm","type":"SC 13D","id":"NTFILEBuVwzVh1yZ4FsQMh","market":"us","size":83119},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1257950/000149315224035871/ex3.htm","primary":false,"translateUrl":"","linkName":"ex3.htm","type":"EX-3","id":"NTFILE2awZkj426qBBQRRb","market":"us","size":22732}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-09-11 12:00","pubTimestamp":1726027200,"title_zh":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18604507","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224035869-SPAI","pdf_url":"","pub_time":1726027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","symbol":"SPAI","title":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035869/0001493152-24-035869-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035869/formsc13d.htm","primary":true,"translateUrl":"","linkName":"formsc13d.htm","type":"SC 13D","id":"NTFILEArZCvK4atvqwhiqu","market":"us","size":76363},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035869/ex3.htm","primary":false,"translateUrl":"","linkName":"ex3.htm","type":"EX-3","id":"NTFILECBpmkLMJHnnRNH6M","market":"us","size":22732}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-09-11 12:00","pubTimestamp":1726027200,"title_zh":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18588186","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224035030-SPAI","pdf_url":"","pub_time":1725495040000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SPAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001493152-24-035030-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035030/ex1-1.htm","primary":true,"translateUrl":"","linkName":"ex1-1.htm","type":"EX-1.1","id":"NTFILE3RgyE3EvC8gBMDKr","market":"us","size":253634},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035030/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEAh1D2fRK9arnTRPq","market":"us","size":39724},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224035030/ex4-1.htm","primary":false,"translateUrl":"","linkName":"ex4-1.htm","type":"EX-4.1","id":"NTFILEG3PHskQeFX7KUvT8","market":"us","size":133950}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-09-05 08:10","pubTimestamp":1725495040,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18601321","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224030995-SPAI","pdf_url":"","pub_time":1723235079000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"SPAI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001493152-24-030995-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224030995/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE57Znc23keKWyZgqN","market":"us","size":11259}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-10 04:24","pubTimestamp":1723235079,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18601331","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315224030942-SPAI","pdf_url":"","pub_time":1723231341000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"SPAI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2011208/0001493152-24-030942-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2011208/000149315224030942/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDUADsuH1xVD6iSKt","market":"us","size":11027}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-10 03:22","pubTimestamp":1723231341,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.safeprogroup.com","stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":0.439},{"period":"3month","weight":-0.2734},{"period":"6month","weight":0.4899},{"period":"1year","weight":-0.41},{"period":"ytd","weight":-0.2298}],"compareEarnings":[{"period":"1week","weight":0.0529},{"period":"1month","weight":0.1304},{"period":"3month","weight":-0.0254},{"period":"6month","weight":0.0144},{"period":"1year","weight":0.1239},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Safe Pro Group Inc.于2021年12月15日在特拉华州注册成立。他们是一家专注于创新安全和保护解决方案的公司，特别是先进的人工智能和机器学习软件技术，用于创建强大的数据集，这些数据集来源于对航空图像、防弹和防爆个人防护设备的分析，并提供关键任务的空中管理服务。","exchange":"NASDAQ","name":"Safe Pro Group Inc","nameEN":"Safe Pro Group Inc"},"aProfile":null}}}